Company: Eli Lilly and Company

Why Amylin Pharmaceuticals shareholders should demand transparency and a public explanation of recent takeover talk.    Read More

TheStreet.com details the 10 most popular high-yielding dividend stocks among Morningstar's Ultimate Stock-Pickers funds, listed in inverse order of highest yield.   Read More

CNBC's quarterly list of S&P 500 stocks with the potential to underperform did just that — they rose by only 5.6 percent since Jan. 10, compared with the 8.8 percent gain for the index.    Read More

Take a look at some of Friday morning's early movers:   Read More

Airport security officials see a lot of things show up in our luggage. Spear guns and tear gas grenades. Snakes. Bathtubs?    Read More

Alkermes expects FDA approval for its new diabetes drug this month, but that might not be enough to make the stock worth buying, trader Guy Adami said.    Read More

With the XPH returning about 11% over the past year, can the relatively defensive Pharma sector continue to perform?   Read More

Consensus among investors says that European gridlock caused a flat performance in U.S. stocks this year. Late next year, however, things will turn around with or without a clear sign of economic upturn in Europe, says Joseph Duran, CEO of wealth-management firm United Capital.   Read More

Cramer makes the call on viewers' favorite stocks.   Read More